Literature DB >> 3824154

Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis.

K D Lillemoe, J L Romolo, S R Hamilton, L R Pennington, J F Burdick, G M Williams.   

Abstract

Five patients who suffered catastrophic colonic necrosis are presented. All patients were uremic and received sodium polystyrene (Kayexalate) in sorbitol enemas for the treatment of hyperkalemia shortly before the development of signs and symptoms of colonic necrosis. In all specimens extensive ischemic necrosis was present, and Kayexalate crystals were noted in the intestinal lumen. Four of the five patients eventually died. To further investigate the occurrence of colonic necrosis after the administration of Kayexalate in sorbitol enemas, a series of experiments were performed in rats. Two groups of Sprague-Dawley rats were studied. One group was made uremic by performance of bilateral nephrectomy. The other group underwent sham operation. Enemas of saline, Kayexalate alone, sorbitol alone, or Kayexalate in sorbitol were administered. In nonuremic rats, transmural necrosis was noted in seven of 10 rats receiving sorbitol enemas and in six of 10 rats receiving Kayexalate in sorbitol enemas. No significant pathologic changes were noted in the rats receiving other enemas. In uremic rats, extensive transmural necrosis was noted in all rats receiving enemas of sorbitol or Kayexalate in sorbitol. All of these 19 rats died within the period of observation compared with no deaths in 18 rats that received enemas without sorbitol (p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3824154

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  31 in total

Review 1.  Colitis: problems in definition and diagnosis.

Authors:  R Whitehead
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Chronic renal failure, hyperkalemia, and colonic ulcers.

Authors:  S A George; M Alboraie; A Maamoun
Journal:  Indian J Nephrol       Date:  2014-05

3.  An unusual cause of recurrent right lower quadrant pain.

Authors:  Sarita Gayle; Martin Kistin; Joshua Hanson
Journal:  Dig Dis Sci       Date:  2014-07       Impact factor: 3.199

Review 4.  New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.

Authors:  Anjay Rastogi; Farid Arman; Setareh Alipourfetrati
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

Review 5.  Treatment of Hyperkalemia in Heart Failure.

Authors:  Ersilia M DeFilippis; Akshay S Desai
Journal:  Curr Heart Fail Rep       Date:  2017-08

6.  Hepatic portal venous gas due to polystyrene sulfonate-induced enteritis.

Authors:  Toshiyuki Kubo; Kentaro Yamashita; Yoshihiro Yokoyama; Daisuke Hirayama; Tomohiro Shirata; Kei Mitsuhashi; Kei Onodera; Eiichiro Yamamoto; Katsuhiko Nosho; Hiroo Yamano; Terufumi Kubo; Shintaro Sugita; Tadashi Hasegawa; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2018-01-22

7.  Colonic necrosis due to sodium polystyrene sulfate (Kayexalate).

Authors:  Andrew S Bomback; John T Woosley; Abhijit V Kshirsagar
Journal:  Am J Emerg Med       Date:  2009-07       Impact factor: 2.469

8.  Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol.

Authors:  C E McGowan; S Saha; G Chu; M B Resnick; S F Moss
Journal:  South Med J       Date:  2009-05       Impact factor: 0.954

9.  Ileocolic perforation secondary to sodium polystyrene sulfonate in sorbitol use: a case report.

Authors:  Vincent Trottier; Sébastian Drolet; Mohib W Morcos
Journal:  Can J Gastroenterol       Date:  2009-10       Impact factor: 3.522

10.  Colonic mucosal necrosis following administration of calcium polystryrene sulfonate (Kalimate) in a uremic patient.

Authors:  Mee Joo; Won Ki Bae; Nam Hoon Kim; Seong Rok Han
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.